Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype

Clinical Endocrinology

Volumn 71, Issue 2, 2009, Pages 253-260

  Tadokoro, Rieko ^b   Bunch, Trevor ^b   Schwabe, John W R ^c   Hughes, Ieuan A ^b   Murphy, Jane C ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADOLESCENT; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CRYSTAL STRUCTURE; FEMALE; GENE DELETION; GENE MUTATION; HORMONE BINDING; HORMONE STRUCTURE; HORMONE SUBSTITUTION; HUMAN; HYPOSPADIAS; IN VITRO STUDY; MALE; MICROPENIS; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; AMINO ACID SEQUENCE; ANDROGEN-INSENSITIVITY SYNDROME; ANDROGENS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHENOTYPE; PROTEIN BINDING; RECEPTORS, ANDROGEN; SEQUENCE ALIGNMENT;

EID: 67650333313     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03462.x     Document Type: Article

References (37)

1. Brinkmann, A.O. (2001) Molecular basis of androgen insensitivity. Molecular and Cellular Endocrinology, 179, 105 109. (Pubitemid 32564957)
2. Tsai, M.J. O'Malley, B.W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry, 63, 451 486. (Pubitemid 24218640)
3. Gottlieb, B., Beitel, L.K., Wu, J.H. et al. (2004) The androgen receptor gene mutations database (ARDB): 2004 update. Human Mutation, 23, 527 533. (Pubitemid 38720602)
4. Gelmann, E.P. (2002) Molecular biology of the androgen receptor. Journal of Clinical Oncology, 20, 3001 3015. (Pubitemid 34728896)
5. Moras, D. Gronemeyer, H. (1998) The nuclear receptor ligand-binding domain: structure and function. Current Opinion in Cell Biology, 10, 384 391. (Pubitemid 28287050)
6. Matias, P.M., Donner, P., Coelho, R. et al. (2000) Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. Journal of Biological Chemistry, 275, 26164 26171. (Pubitemid 30676662)
7. Voegel, J.J., Heine, M.J., Zechel, C. et al. (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. The EMBO Journal, 15, 3667 3675. (Pubitemid 26239779)
8. Bevan, C.L., Hoare, S., Claessens, F. et al. (1999) The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Molecular and Cellular Biology, 19, 8383 8392. (Pubitemid 30414032)
9. Berrevoets, C.A., Doesburg, P., Steketee, K. et al. (1998) Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Molecular Endocrinology, 12, 1172 1183. (Pubitemid 30659044)
10. Adachi, H., Katsuno, M., Minamiyama, M. et al. (2003) Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. The Journal of Neuroscience, 23, 2203 2211. (Pubitemid 36368908)
11. Newmark, J.R., Hardy, D.O., Tonb, D.C. et al. (1992) Androgen receptor gene mutations in human prostate cancer. Proceedings of the National Academy of Sciences United States of America, 89, 6319 6323.
12. Marcelli, M., Ittmann, M., Mariani, S. et al. (2000) Androgen receptor mutations in prostate cancer. Cancer Research, 60, 944 949. (Pubitemid 30129530)
13. Taplin, M.E., Bubley, G.J., Shuster, T.D. et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. The New England Journal of Medicine, 332, 1393 1398.
14. Haapala, K., Hyytinen, E.R., Roiha, M. et al. (2001) Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide. Laboratory Investigation, 81, 1647 1651. (Pubitemid 33144427)
15. Hyytinen, E.R., Haapala, K., Thompson, J. et al. (2002) Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer. Laboratory Investigation, 82, 1591 1598. (Pubitemid 35332918)
16. Zhao, X.Y., Malloy, P.J., Krishnan, A.V. et al. (2000) Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nature Medicine, 6, 703 706. (Pubitemid 30398797)
17. Sack, J.S., Kish, K.F., Wang, C. et al. (2001) Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proceedings of the National Academy of Sciences United States of America, 98, 4904 4909. (Pubitemid 32397055)
18. Hiort, O., Wodtke, A., Struve, D. et al. (1994) Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis. German Collaborative Intersex Study Group. Human Molecular Genetics, 3, 1163 1166. (Pubitemid 24211964)
19. Weidemann, W., Linck, B., Haupt, H. et al. (1996) Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. Clinical Endocrinology, 45, 733 739. (Pubitemid 27032320)
20. Schwartz, M., Skovby, F., Mueller, J. et al. (1994) Partial androgen insensitivity (PAIS) in a large eskimo kindred caused by a delD690 mutation in the androgen receptor (AR) gene (Abstract 244). Hormone Research, 41, 117 117.
21. Hiort, O., Sinnecker, G.H., Holterhus, P.M. et al. (1996) The clinical and molecular spectrum of androgen insensitivity syndromes. American Journal of Medical Genetics, 63, 218 222.
22. Hannema, S.E., Scott, I.S., Hodapp, J. et al. (2004) Residual activity of mutant androgen receptors explains Wolffian duct development in the complete androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism, 89, 5815 5822. (Pubitemid 39518476)
23. Deeb, A., Mason, C., Lee, Y.S. et al. (2005) Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clinical Endocrinology, 63, 56 62. (Pubitemid 40966403)
24. Bevan, C.L., Brown, B.B., Davies, H.R. et al. (1996) Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome. Human Molecular Genetics, 5, 265 273. (Pubitemid 26036922)
25. Lubahn, D.B., Joseph, D.R., Sar, M. et al. (1988) The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Molecular Endocrinology, 2, 1265 1275. (Pubitemid 19005939)
26. Brinkmann, A.O., Faber, P.W., van Rooij, H.C. et al. (1989) The human androgen receptor: domain structure, genomic organization and regulation of expression. Journal of Steroid Biochemistry, 34, 307 310. (Pubitemid 20061799)
27. Knoke, I., Allera, A. Wieacker, P. (1999) Significance of the CAG repeat length in the androgen receptor gene (AR) for the transactivation function of an M780I mutant AR. Human Genetics, 104, 257 261. (Pubitemid 29182606)
28. He, B., Lee, L.W., Minges, J.T. et al. (2002) Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. Journal of Biological Chemistry, 277, 25631 25639. (Pubitemid 34951881)
29. Takahashi, H., Furusato, M., Allsbrook, W.C. Jr et al. (1995) Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Research, 55, 1621 1624.
30. Callewaert, L., Verrijdt, G., Christiaens, V. et al. (2003) Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements. The Journal of Biological Chemistry, 278, 8212 8218. (Pubitemid 36800564)
31. Thompson, J., Saatcioglu, F., Janne, O.A. et al. (2001) Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Molecular Endocrinology, 15, 923 935. (Pubitemid 32510639)
32. Werner, R., Holterhus, P.M., Binder, G. et al. (2006) The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. Journal of Clinical Endocrinology and Metabolism, 91, 3515 3520. (Pubitemid 44402130)
33. Rajender, S., Gupta, N.J., Chakravarty, B. et al. (2008) Androgen insensitivity syndrome: do trinucleotide repeats in androgen receptor gene have any role? Asian Journal of Andrology, 10, 616 624. (Pubitemid 351865768)
34. Balducci, R., Ghirri, P., Brown, T.R. et al. (1996) A clinician looks at androgen resistance. Steroids, 61, 205 211. (Pubitemid 26144424)
35. Kolon, T.F. (2008) Disorders of sexual development. Current Urology Reports, 9, 172 177.
36. Evans, B.A., Hughes, I.A., Bevan, C.L. et al. (1997) Phenotypic diversity in siblings with partial androgen insensitivity syndrome. Archives of Disease in Childhood, 76, 529 531. (Pubitemid 27334724)
37. Chu, J., Zhang, R., Zhao, Z. et al. (2002) Male fertility is compatible with an Arg (840) Cys substitution in the AR in a large Chinese family affected with divergent phenotypes of AR insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 347 351. (Pubitemid 34084713)